Loading…

Mass vaccination campaign following community outbreak of meningococcal disease

During December 12-29, 1998, seven patients ages 2-18 years were diagnosed with serogroup C meningococcal disease in two neighboring Florida towns with 33,000 residents. We evaluated a mass vaccination campaign implemented to control the outbreak. We maintained vaccination logs and recorded the reso...

Full description

Saved in:
Bibliographic Details
Published in:Emerging infectious diseases 2002-12, Vol.8 (12), p.1398-1403
Main Authors: Krause, Gérard, Blackmore, Carina, Wiersma, Steven, Lesneski, Cheryll, Gauch, Laurey, Hopkins, Richard S
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c533t-b64d385e2f391493711676d7e200fed7fe6ef3f764cf6fa910f12579b1f333953
cites cdi_FETCH-LOGICAL-c533t-b64d385e2f391493711676d7e200fed7fe6ef3f764cf6fa910f12579b1f333953
container_end_page 1403
container_issue 12
container_start_page 1398
container_title Emerging infectious diseases
container_volume 8
creator Krause, Gérard
Blackmore, Carina
Wiersma, Steven
Lesneski, Cheryll
Gauch, Laurey
Hopkins, Richard S
description During December 12-29, 1998, seven patients ages 2-18 years were diagnosed with serogroup C meningococcal disease in two neighboring Florida towns with 33,000 residents. We evaluated a mass vaccination campaign implemented to control the outbreak. We maintained vaccination logs and recorded the resources used in the campaign that targeted 2- to 22-year-old residents of the two towns. A total of 13,148 persons received the vaccinations in 3 days. Vaccination coverage in the target population was estimated to be 86% to 99%. Five additional cases of serogroup C meningococcal disease occurred in the community during the year after the campaign began, four in patients who had not received the vaccine. The cost of control efforts was approximately $370,000. Although cases continued to occur, the vaccination campaign appeared to control the outbreak. Rapid implementation, a targeted approach, and high coverage were important to the campaign's success.
doi_str_mv 10.3201/eid0812.040421
format article
fullrecord <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_72787502</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A95909371</galeid><sourcerecordid>A95909371</sourcerecordid><originalsourceid>FETCH-LOGICAL-c533t-b64d385e2f391493711676d7e200fed7fe6ef3f764cf6fa910f12579b1f333953</originalsourceid><addsrcrecordid>eNqN0s1rFDEYB-Agiq3Vq0eZi-LBWfOdybEUPwqVBb-uIZt5M41mknWSUfvfO8su6kJBySEhed6XkPwQekzwilFMXkLocUfoCnPMKbmDTgnucCux0Hd_rzk-QQ9K-YIxWUr0fXRCKNedFPwUrd_ZUprv1rmQbA05Nc6OWxuG1PgcY_4R0tC4PI5zCvWmyXPdTGC_Ntk3I6TlMLvsnI1NHwrYAg_RPW9jgUeH-Qx9ev3q48Xb9mr95vLi_Kp1grHabiTvWSeAeqYJ10wRIpXsFVCMPfTKgwTPvJLceemtJtgTKpTeEM8Y04KdoWf7vtspf5uhVDOG4iBGmyDPxSiqOiUw_SckWvKOiG6BL_ZwsBFMSD7XyboBEkw25gQ-LNvnWmi8u-7C21v4MnoYg7vNPz_yC6nwsw52LsVcfnj_33T9-Yg-_Yteg431uuQ4736yHLnV3rkplzKBN9spjHa6MQSbXZDMIUhmH6Sl4Mnh2ebNCP0ffkgO-wWsjMDx</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>19648158</pqid></control><display><type>article</type><title>Mass vaccination campaign following community outbreak of meningococcal disease</title><source>Open Access: PubMed Central</source><creator>Krause, Gérard ; Blackmore, Carina ; Wiersma, Steven ; Lesneski, Cheryll ; Gauch, Laurey ; Hopkins, Richard S</creator><creatorcontrib>Krause, Gérard ; Blackmore, Carina ; Wiersma, Steven ; Lesneski, Cheryll ; Gauch, Laurey ; Hopkins, Richard S</creatorcontrib><description>During December 12-29, 1998, seven patients ages 2-18 years were diagnosed with serogroup C meningococcal disease in two neighboring Florida towns with 33,000 residents. We evaluated a mass vaccination campaign implemented to control the outbreak. We maintained vaccination logs and recorded the resources used in the campaign that targeted 2- to 22-year-old residents of the two towns. A total of 13,148 persons received the vaccinations in 3 days. Vaccination coverage in the target population was estimated to be 86% to 99%. Five additional cases of serogroup C meningococcal disease occurred in the community during the year after the campaign began, four in patients who had not received the vaccine. The cost of control efforts was approximately $370,000. Although cases continued to occur, the vaccination campaign appeared to control the outbreak. Rapid implementation, a targeted approach, and high coverage were important to the campaign's success.</description><identifier>ISSN: 1080-6040</identifier><identifier>EISSN: 1080-6059</identifier><identifier>DOI: 10.3201/eid0812.040421</identifier><identifier>PMID: 12498654</identifier><language>eng</language><publisher>United States: U.S. National Center for Infectious Diseases</publisher><subject>Adolescent ; Adult ; Child ; Child, Preschool ; Community Health Services - economics ; Community Health Services - statistics &amp; numerical data ; Disease Outbreaks ; Female ; Florida - epidemiology ; Humans ; Immunization ; Immunization of infants ; Infant ; Infants ; Male ; Management ; Mass Vaccination - economics ; Mass Vaccination - statistics &amp; numerical data ; Meningitis, Meningococcal - epidemiology ; Meningitis, Meningococcal - prevention &amp; control ; Meningococcal Vaccines - administration &amp; dosage ; Meningococcal Vaccines - therapeutic use ; Neisseria meningitidis ; Prevention ; Public health ; Public Health - economics</subject><ispartof>Emerging infectious diseases, 2002-12, Vol.8 (12), p.1398-1403</ispartof><rights>COPYRIGHT 2002 U.S. National Center for Infectious Diseases</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c533t-b64d385e2f391493711676d7e200fed7fe6ef3f764cf6fa910f12579b1f333953</citedby><cites>FETCH-LOGICAL-c533t-b64d385e2f391493711676d7e200fed7fe6ef3f764cf6fa910f12579b1f333953</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12498654$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Krause, Gérard</creatorcontrib><creatorcontrib>Blackmore, Carina</creatorcontrib><creatorcontrib>Wiersma, Steven</creatorcontrib><creatorcontrib>Lesneski, Cheryll</creatorcontrib><creatorcontrib>Gauch, Laurey</creatorcontrib><creatorcontrib>Hopkins, Richard S</creatorcontrib><title>Mass vaccination campaign following community outbreak of meningococcal disease</title><title>Emerging infectious diseases</title><addtitle>Emerg Infect Dis</addtitle><description>During December 12-29, 1998, seven patients ages 2-18 years were diagnosed with serogroup C meningococcal disease in two neighboring Florida towns with 33,000 residents. We evaluated a mass vaccination campaign implemented to control the outbreak. We maintained vaccination logs and recorded the resources used in the campaign that targeted 2- to 22-year-old residents of the two towns. A total of 13,148 persons received the vaccinations in 3 days. Vaccination coverage in the target population was estimated to be 86% to 99%. Five additional cases of serogroup C meningococcal disease occurred in the community during the year after the campaign began, four in patients who had not received the vaccine. The cost of control efforts was approximately $370,000. Although cases continued to occur, the vaccination campaign appeared to control the outbreak. Rapid implementation, a targeted approach, and high coverage were important to the campaign's success.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Community Health Services - economics</subject><subject>Community Health Services - statistics &amp; numerical data</subject><subject>Disease Outbreaks</subject><subject>Female</subject><subject>Florida - epidemiology</subject><subject>Humans</subject><subject>Immunization</subject><subject>Immunization of infants</subject><subject>Infant</subject><subject>Infants</subject><subject>Male</subject><subject>Management</subject><subject>Mass Vaccination - economics</subject><subject>Mass Vaccination - statistics &amp; numerical data</subject><subject>Meningitis, Meningococcal - epidemiology</subject><subject>Meningitis, Meningococcal - prevention &amp; control</subject><subject>Meningococcal Vaccines - administration &amp; dosage</subject><subject>Meningococcal Vaccines - therapeutic use</subject><subject>Neisseria meningitidis</subject><subject>Prevention</subject><subject>Public health</subject><subject>Public Health - economics</subject><issn>1080-6040</issn><issn>1080-6059</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><recordid>eNqN0s1rFDEYB-Agiq3Vq0eZi-LBWfOdybEUPwqVBb-uIZt5M41mknWSUfvfO8su6kJBySEhed6XkPwQekzwilFMXkLocUfoCnPMKbmDTgnucCux0Hd_rzk-QQ9K-YIxWUr0fXRCKNedFPwUrd_ZUprv1rmQbA05Nc6OWxuG1PgcY_4R0tC4PI5zCvWmyXPdTGC_Ntk3I6TlMLvsnI1NHwrYAg_RPW9jgUeH-Qx9ev3q48Xb9mr95vLi_Kp1grHabiTvWSeAeqYJ10wRIpXsFVCMPfTKgwTPvJLceemtJtgTKpTeEM8Y04KdoWf7vtspf5uhVDOG4iBGmyDPxSiqOiUw_SckWvKOiG6BL_ZwsBFMSD7XyboBEkw25gQ-LNvnWmi8u-7C21v4MnoYg7vNPz_yC6nwsw52LsVcfnj_33T9-Yg-_Yteg431uuQ4736yHLnV3rkplzKBN9spjHa6MQSbXZDMIUhmH6Sl4Mnh2ebNCP0ffkgO-wWsjMDx</recordid><startdate>200212</startdate><enddate>200212</enddate><creator>Krause, Gérard</creator><creator>Blackmore, Carina</creator><creator>Wiersma, Steven</creator><creator>Lesneski, Cheryll</creator><creator>Gauch, Laurey</creator><creator>Hopkins, Richard S</creator><general>U.S. National Center for Infectious Diseases</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>7QL</scope><scope>C1K</scope><scope>7X8</scope></search><sort><creationdate>200212</creationdate><title>Mass vaccination campaign following community outbreak of meningococcal disease</title><author>Krause, Gérard ; Blackmore, Carina ; Wiersma, Steven ; Lesneski, Cheryll ; Gauch, Laurey ; Hopkins, Richard S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c533t-b64d385e2f391493711676d7e200fed7fe6ef3f764cf6fa910f12579b1f333953</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Community Health Services - economics</topic><topic>Community Health Services - statistics &amp; numerical data</topic><topic>Disease Outbreaks</topic><topic>Female</topic><topic>Florida - epidemiology</topic><topic>Humans</topic><topic>Immunization</topic><topic>Immunization of infants</topic><topic>Infant</topic><topic>Infants</topic><topic>Male</topic><topic>Management</topic><topic>Mass Vaccination - economics</topic><topic>Mass Vaccination - statistics &amp; numerical data</topic><topic>Meningitis, Meningococcal - epidemiology</topic><topic>Meningitis, Meningococcal - prevention &amp; control</topic><topic>Meningococcal Vaccines - administration &amp; dosage</topic><topic>Meningococcal Vaccines - therapeutic use</topic><topic>Neisseria meningitidis</topic><topic>Prevention</topic><topic>Public health</topic><topic>Public Health - economics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Krause, Gérard</creatorcontrib><creatorcontrib>Blackmore, Carina</creatorcontrib><creatorcontrib>Wiersma, Steven</creatorcontrib><creatorcontrib>Lesneski, Cheryll</creatorcontrib><creatorcontrib>Gauch, Laurey</creatorcontrib><creatorcontrib>Hopkins, Richard S</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Opposing Viewpoints In Context</collection><collection>Gale In Context: Science</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Environmental Sciences and Pollution Management</collection><collection>MEDLINE - Academic</collection><jtitle>Emerging infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Krause, Gérard</au><au>Blackmore, Carina</au><au>Wiersma, Steven</au><au>Lesneski, Cheryll</au><au>Gauch, Laurey</au><au>Hopkins, Richard S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Mass vaccination campaign following community outbreak of meningococcal disease</atitle><jtitle>Emerging infectious diseases</jtitle><addtitle>Emerg Infect Dis</addtitle><date>2002-12</date><risdate>2002</risdate><volume>8</volume><issue>12</issue><spage>1398</spage><epage>1403</epage><pages>1398-1403</pages><issn>1080-6040</issn><eissn>1080-6059</eissn><abstract>During December 12-29, 1998, seven patients ages 2-18 years were diagnosed with serogroup C meningococcal disease in two neighboring Florida towns with 33,000 residents. We evaluated a mass vaccination campaign implemented to control the outbreak. We maintained vaccination logs and recorded the resources used in the campaign that targeted 2- to 22-year-old residents of the two towns. A total of 13,148 persons received the vaccinations in 3 days. Vaccination coverage in the target population was estimated to be 86% to 99%. Five additional cases of serogroup C meningococcal disease occurred in the community during the year after the campaign began, four in patients who had not received the vaccine. The cost of control efforts was approximately $370,000. Although cases continued to occur, the vaccination campaign appeared to control the outbreak. Rapid implementation, a targeted approach, and high coverage were important to the campaign's success.</abstract><cop>United States</cop><pub>U.S. National Center for Infectious Diseases</pub><pmid>12498654</pmid><doi>10.3201/eid0812.040421</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1080-6040
ispartof Emerging infectious diseases, 2002-12, Vol.8 (12), p.1398-1403
issn 1080-6040
1080-6059
language eng
recordid cdi_proquest_miscellaneous_72787502
source Open Access: PubMed Central
subjects Adolescent
Adult
Child
Child, Preschool
Community Health Services - economics
Community Health Services - statistics & numerical data
Disease Outbreaks
Female
Florida - epidemiology
Humans
Immunization
Immunization of infants
Infant
Infants
Male
Management
Mass Vaccination - economics
Mass Vaccination - statistics & numerical data
Meningitis, Meningococcal - epidemiology
Meningitis, Meningococcal - prevention & control
Meningococcal Vaccines - administration & dosage
Meningococcal Vaccines - therapeutic use
Neisseria meningitidis
Prevention
Public health
Public Health - economics
title Mass vaccination campaign following community outbreak of meningococcal disease
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T01%3A12%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Mass%20vaccination%20campaign%20following%20community%20outbreak%20of%20meningococcal%20disease&rft.jtitle=Emerging%20infectious%20diseases&rft.au=Krause,%20G%C3%A9rard&rft.date=2002-12&rft.volume=8&rft.issue=12&rft.spage=1398&rft.epage=1403&rft.pages=1398-1403&rft.issn=1080-6040&rft.eissn=1080-6059&rft_id=info:doi/10.3201/eid0812.040421&rft_dat=%3Cgale_proqu%3EA95909371%3C/gale_proqu%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c533t-b64d385e2f391493711676d7e200fed7fe6ef3f764cf6fa910f12579b1f333953%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=19648158&rft_id=info:pmid/12498654&rft_galeid=A95909371&rfr_iscdi=true